Today the FDA called for stronger warning labels on four of the largest selling Crohn's disease drugs: Remicade, Humira, Enbrel, and Cimzia.
The call for stricter warning labels are a result of the increased risk of serious fungal infections associated with the drugs. Specifically, the FDA reported 240 cases of histoplasmosis in patients taking the drugs. Histoplasmosis is a respiratory disease with flu like symptoms. If untreated the disease is deadly.
For the full story, read the Wall Street Journal's article here.
- Font size
- Email This
- Bookmark
- Thank you for your input
- Save
- RSS
- Report Abuse
What the community is saying...
Skin Cancer and IBD Medications
Posted 11/02 Comments (0)
According to a recent study of 26,403 Crohn's disease...
